IONIS
Live / Applied — New application — assigned to an examiner (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 23 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99666317
- Mark type
- Stylized text
- Filed
- 23 Feb 2026
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances, biological preparations and substances, therapeutic preparations and substances, namely, nucleic acid-targeted therapeutics; Pharmaceutical preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Biological preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders; Therapeutic preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, cardiovascular, neurologic, pulmonary, inflammatory, renal, metabolic, ophthalmologic, and rare diseases and disorders
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prior registrations
Prosecution history
- 02 Apr 2026 — ASSIGNED TO EXAMINER
- 23 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Feb 2026 — NEW APPLICATION ENTERED